Search

President Biden announced on September 15 his appointment of MSK medical oncologist and Head of the Division of Solid Tumor Oncology, Luis Alberto Diaz, Jr., MD, as one of seven distinguished members of the National Cancer Advisory Board.

… Thursday, September 16, 2021 President Biden announced on September 15 his appointment of Memorial Sloan Kettering Cancer Center (MSK) medical oncologist and Head of the Division of Solid Tumor Oncology, Luis Alberto Diaz, Jr., MD , as one of seven distinguished members of the National Cancer Advisory

MSK Kids is continuously investigating new ways to improve outcomes and the quality of life for pediatric patients with high-risk neuroblastoma. In this article we detail highlights of the latest clinical and molecular research advances for pediatric neuroblastoma.

… Thursday, September 25, 2025 MSK Kids has one of the largest teams of neuroblastoma experts and treats the highest volume of pediatric patients with neuroblastoma in the United States. Today, more than half of children with metastatic neuroblastoma survive, a 10-fold improvement since the 1980s, primarily

Meet the man who helped make the Gerstner Sloan Kettering Graduate School of Biomedical Sciences a reality.

… Wednesday, October 24, 2018 Ken Marians Dr. Marians welcoming GSK students and undergraduates to the Frontiers of Science program in 2011. Ken Marians and Lou Gerstner Dr. Marians with Louis V. Gerstner, Jr., GSK's Chairman, at the first commencement ceremony in 2012. graduates Dr. Marians, Mr. Gerstner

Improved understanding of the biology and molecular subtypes of non-small cell lung cancer (NSCLC) has led to the development of several biomarker-targeted therapies for patients with locally advanced and metastatic disease.

… Monday, November 11, 2019 Improved understanding of the biology and molecular subtypes of non-small cell lung cancer (NSCLC) has led to the development of several biomarker-targeted therapies for patients with locally advanced and metastatic disease. Cytotoxic chemotherapy remains an essential component

A study identifies genetic variations that alter the risk of breast cancer in women who have a certain gene mutation.

… Thursday, March 28, 2013 Summary A study identifies genetic variations that alter the risk of breast cancer in women who have a certain gene mutation. Since the first inherited genes for breast cancer were found in the mid-1990s, researchers have been looking for more-accurate ways to predict which women

Ivan Maillard, MD, PhD, has been named Head of the Division of Hematologic Malignancies within the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK).

… Monday, November 4, 2024 Ivan Maillard, MD, PhD , has been named Head of the Division of Hematologic Malignancies within the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK). A physician-scientist, Dr. Maillard is a practicing hematologist-oncologist with experience treating lymphoma

Beginning in April 2013, physician-scientist Charles Sawyers will serve as President of the American Association for Cancer Research, the world’s oldest and largest professional organization dedicated to advancing cancer research.

… Tuesday, March 20, 2012 Summary Beginning in April 2013, physician-scientist Charles Sawyers will serve as President of the American Association for Cancer Research, the world’s oldest and largest professional organization dedicated to advancing cancer research. Memorial Sloan Kettering physician-scientist

The quantity of tests and treatments a cancer patient undergoes could depend largely on where he or she receives care, according to an analysis by researchers at Memorial Sloan Kettering (MSK).

… Monday, April 6, 2015 From radioactive PET scans to costly chemotherapy doses, the quantity of tests and treatments a cancer patient undergoes could depend largely on where he or she receives care, according to an analysis by researchers at Memorial Sloan Kettering (MSK) and others, including Jeffrey

Today, after a yearlong review and collaborative process, Miami Cancer Institute at Baptist Health South Florida became a full member of the Memorial Sloan Kettering (MSK) Cancer Alliance. Miami Cancer Institute is the third member of the MSK Cancer Alliance, a transformative initiative that aims to improve the quality of care and outcomes for people with cancer in community settings.

… Thursday, January 26, 2017 Today, after a yearlong review and collaborative process, Miami Cancer Institute at Baptist Health South Florida became a full member of the Memorial Sloan Kettering (MSK) Cancer Alliance . Miami Cancer Institute is the third member of the MSK Cancer Alliance, a transformative

Identified in mice, this unusual cell state emerges early during tumor evolution and gives tumors enormous malleability.

… Thursday, July 23, 2020 Summary Scientists at the Sloan Kettering Institute , the Koch Institute at MIT , and the Klarman Cell Observatory at the Broad Institute have identified an unusual cell state that emerges early in tumor evolution and supports a cancer’s ability to outwit chemotherapy. Cancer’